Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Sponsor
The Cleveland Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT00281814
Collaborator
National Cancer Institute (NCI) (NIH)
36
1
131.1
0.3
Study Details
Study Description
Brief Summary
RATIONALE: Questionnaires that measure coping may improve the ability to plan supportive care for patients undergoing donor bone marrow transplant.
PURPOSE: This clinical trial is studying coping in patients who are undergoing a donor bone marrow transplant.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
OBJECTIVES:
- Investigate the relative importance of having a consistent inpatient lay care-partner for patients undergoing allogeneic bone marrow transplantation, in terms of the effects on modes of adjustment to illness and survival.
OUTLINE: Patients undergo a 40-minute recorded oral interview in person to provide personal and social demographic data using a 20-item questionnaire (The Adjustment to Illness Questionnaire-Bone Marrow Transplantation) at baseline (pre-transplant) and at day 100 post-transplant.
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
Study Design
Study Type:
Observational
Actual Enrollment
:
36 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support
Actual Study Start Date
:
Feb 1, 2006
Actual Primary Completion Date
:
Dec 31, 2008
Actual Study Completion Date
:
Jan 4, 2017
Outcome Measures
Primary Outcome Measures
- Compare modes of illness adjustment, presence or absence of an inpatient lay care-partner, and survival rates [Through 100 days post transplant]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
- Medically suitable for allogeneic bone marrow transplantation
PATIENT CHARACTERISTICS:
- Resides locally in the Cleveland, Ohio area
PRIOR CONCURRENT THERAPY:
- Not specified
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center | Cleveland | Ohio | United States | 44195 |
Sponsors and Collaborators
- The Cleveland Clinic
- National Cancer Institute (NCI)
Investigators
- Study Chair: Brian J. Bolwell, MD, Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Navneet Majhail, MD,
Director Blood & Marrow Transplant Program,
The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00281814
Other Study ID Numbers:
- CASE-CCF-6950
- P30CA043703
- CASE-CCF-6950
- CASE-CCF-1035
First Posted:
Jan 25, 2006
Last Update Posted:
Jan 26, 2018
Last Verified:
Jan 1, 2018
Keywords provided by Navneet Majhail, MD,
Director Blood & Marrow Transplant Program,
The Cleveland Clinic
Additional relevant MeSH terms: